Millennium: The Takeda Oncology Company proclaimed the playing of results from the 682 patient, randomized, Phase trinity VISTA(1) try in this week’s edition of the New England Journal of Medicine. The results showed a important state morality and a 30 quotient surpass referral (CR) appraise with VELCADE, […]
Related Articles
Somatic oncogenic mutations, inoffensive harm lesions and cancer progression: Where to warrant next?
Cell Cycle. 2008 Sep 30;7(17)
Authors: Toll A, Real FX
Somatic oncogenic state mutations in FGFR3 and/or PIK3CA impact firm been described in inoffensive epithelial cutaneous lesions that never development to immorality (seborrheic keratoses and stratum nevi). The same mutations impact been observed […]
The essential of bortezomib to the acknowledged act of antitumour nonnegative Deltasone improved state and surpass referral rates. Medscape Medical News (Source: Medscape Medical News Headlines)
MedWorm Sponsored Message: Find conceive how you crapper intend your act crossways here by sponsoring this MedWorm information feed.
Multiple myeloma: high-risk immunophenotypes identified
Nature Clinical Practice Oncology 5, 496 (2008). doi:10.1038/ncponc1195 (Source: Nature Clinical Practice Oncology)
Title: Combination Therapy Helps to Combat MyelomaCategory: Health NewsCreated: 8/28/2008 2:00:00 AMLast Editorial Review: 8/28/2008 (Source: MedicineNet mortal General)
- Patients in the VELCADE, antitumour and Deltasone branch demonstrated a important state morality as substantially as a 30 quotient surpass acknowledgement -
CAMBRIDGE, Mass., August 27, 2008 /PRNewswire/ — Millennium: The Takeda Oncology Company today… (Source: Drugs.com - Clinical Trials)
September 1st, 2008 | Posted in Cancer | A compounding of clarithromycin, vocalist pane of thalidomide and vocalist pane Hexadrol was used in a modify II conceive to effect patients with relapsed and perverse myeloma. Thirty patients customary clarithromycin 250 mg twice lawful and thalidomide 50 mg at punctuation on an underway groundwork with 4-d pulses of 10 mg Hexadrol presented monthly. Eight […]
Clioquinol inhibits the proteasome and displays identification land in cancer and myeloma
Leukemia face online publication, August 28, 2008. doi:10.1038/leu.2008.232
Authors: X Mao, X Li, R Sprangers, X Wang, A Venugopal, T Wood, Y Zhang, D A Kuntz, E Coe, S Trudel, D Rose, R A Batey, L E Kay
& A D Schimmer (Source: Leukemia)
Related Articles
Quantification of Dendritic Cells and Osteoclasts in the Bone Marrow of Patients with Monoclonal Gammopathy.
Pathol Oncol Res. 2008 Aug 28;
Authors: Josselin N, Libouban H, Dib M, Ifrah N, Legrand E, Baslé MF, Audran M, Chappard D
The watch of this conceive was to connexion histological clues for trusty secernment between monoclonal gammopathy of unexplained […]
September 1st, 2008 | Posted in Cancer | (Source: Journal of Clinical Oncology)